Medications & Substances

Vivitrol.

Vivitrol is a monthly extended-release injection of naltrexone, an opioid antagonist. How it works, who it suits, and how it compares to buprenorphine.

All topics

Medically reviewed by N Elias, MD, board-certified in addiction medicine·Last reviewed May 2026

Looking for treatment? Same-day visits usually available. No insurance required.

Call or text Book online

MyStreetHealth prescribes buprenorphine (Suboxone and Subutex) — not Vivitrol. This page is here because patients often ask how Vivitrol compares. If Vivitrol is the right fit for you, a provider who offers it can help. If you are looking for buprenorphine treatment, we are here for that — call or text (888) 835-9995.

What is Vivitrol and how does it work?

Vivitrol is a monthly injection of naltrexone that blocks opioid receptors. It prevents opioids from having an effect but requires patients to be fully detoxed before starting. It is one of several medication options for opioid use disorder.

What Vivitrol is

A monthly naltrexone injection.

Vivitrol is the brand name for extended-release injectable naltrexone — an intramuscular injection administered once monthly by a clinician. It contains naltrexone microspheres suspended in a biodegradable polymer that releases medication over 30 days.

Naltrexone is an opioid antagonist — it completely blocks opioid receptors. Patients on Vivitrol generally have opioid receptor blockade during the injection's active period, which reduces or prevents the effects of opioids. Unlike buprenorphine and methadone, naltrexone is not itself an opioid and has no misuse potential.

Requirements and considerations

Vivitrol requires a period of complete opioid abstinence first.

The most significant clinical constraint on Vivitrol is that patients generally need to be fully opioid-free before the first injection, often for about 7–10 days depending on the opioid involved and the clinical situation. If naltrexone is administered while opioids are still present, it will precipitate acute withdrawal, which can be severe.

This requirement is a real barrier in practice. The required opioid-free period can make initiation difficult, and some patients do not successfully complete that transition.

The period between stopping opioids and receiving the first Vivitrol injection carries high return-to-use risk and reduced opioid tolerance — making overdose particularly dangerous if a return to use occurs.

Comparison with buprenorphine

Different medications for different clinical situations.

Initiation

Buprenorphine can be started while a patient is still opioid-dependent — no prior abstinence required. Vivitrol requires complete opioid-free status.

Mechanism

Buprenorphine is a partial agonist — it reduces withdrawal and cravings by partially activating receptors. Vivitrol is a pure antagonist — it blocks receptors entirely and does not address withdrawal or craving in the same way.

Evidence

Both are FDA-approved and evidence-based. A large NIDA-funded trial (X:BOT, 2018) found comparable outcomes between extended-release naltrexone and buprenorphine/naloxone for those who successfully initiated treatment — but significantly lower initiation rates for naltrexone due to the abstinence requirement.

Who may benefit

Vivitrol may be appropriate for patients who have completed a supervised opioid-free period and prefer an opioid antagonist approach, or for patients in settings where opioid-based medication is unavailable or declined — such as certain criminal justice or professional licensing contexts.

Sources

Where this information comes from.

Landmark RCT

Lee et al. — X:BOT Trial, Lancet (2018)

NEJM. Extended-release naltrexone vs. buprenorphine/naloxone — comparable outcomes among those who initiated, but lower initiation rates with naltrexone.

FDA

Vivitrol Prescribing Information

Official FDA prescribing information for extended-release injectable naltrexone.

ASAM

ASAM National Practice Guideline (2020)

Clinical guidance on naltrexone including patient selection, initiation, and management.

Related

← All Learn topics  ·  Naloxone vs naltrexone  ·  What is Suboxone  ·  Methadone vs Suboxone

MyStreetHealth serves

Virginia  ·  Maryland  ·  Washington DC  ·  West Virginia  ·  Ohio

Common questions

Frequently asked

How often is Vivitrol injected?

Vivitrol is given as a monthly intramuscular injection, typically in a clinical setting.

What happens if I use opioids while on Vivitrol?

Naltrexone blocks opioid receptors, so opioids may have little to no effect while Vivitrol is active. Attempting to override the block with large doses is dangerous and has caused fatal overdoses.

Can Vivitrol be used for alcohol use disorder?

Yes. Naltrexone is FDA-approved for both opioid use disorder and alcohol use disorder. Vivitrol is used for both indications.

Also on this site

Questions about treatment?

Same-day visits usually available.

(888) 835-9995 · Call or text Book online LegitScript verified
Home
Patient login Book online